Andrea Tan
Stock Analyst at Goldman Sachs
(1.55)
# 3,483
Out of 5,051 analysts
48
Total ratings
42.11%
Success rate
-8.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrea Tan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $196 → $225 | $186.88 | +20.40% | 13 | Oct 31, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $16 → $8 | $1.81 | +341.99% | 7 | May 12, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Neutral | $46 → $51 | $68.20 | -25.22% | 4 | May 5, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $39 → $27 | $9.14 | +195.40% | 6 | Mar 25, 2025 | |
| SGMT Sagimet Biosciences | Maintains: Neutral | $23 → $6 | $7.77 | -22.78% | 5 | Jul 1, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Neutral | $31 | $40.31 | -23.10% | 1 | Jun 5, 2024 | |
| RLMD Relmada Therapeutics | Downgrades: Sell | $3 → $2 | $2.51 | -20.32% | 3 | Jun 5, 2024 | |
| KOD Kodiak Sciences | Reinstates: Sell | $2 | $17.83 | -88.78% | 1 | Dec 11, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $160 | $199.88 | -19.95% | 1 | Nov 20, 2023 | |
| ABCL AbCellera Biologics | Maintains: Buy | $27 → $24 | $4.69 | +411.73% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $10 → $4 | $1.09 | +266.97% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $178 → $375 | $475.87 | -21.20% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $80 | $20.91 | +282.59% | 2 | May 24, 2022 |
Insmed
Oct 31, 2025
Maintains: Buy
Price Target: $196 → $225
Current: $186.88
Upside: +20.40%
Iovance Biotherapeutics
May 12, 2025
Maintains: Buy
Price Target: $16 → $8
Current: $1.81
Upside: +341.99%
Tarsus Pharmaceuticals
May 5, 2025
Maintains: Neutral
Price Target: $46 → $51
Current: $68.20
Upside: -25.22%
Day One Biopharmaceuticals
Mar 25, 2025
Maintains: Buy
Price Target: $39 → $27
Current: $9.14
Upside: +195.40%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23 → $6
Current: $7.77
Upside: -22.78%
Arrowhead Pharmaceuticals
Jun 5, 2024
Initiates: Neutral
Price Target: $31
Current: $40.31
Upside: -23.10%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3 → $2
Current: $2.51
Upside: -20.32%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $17.83
Upside: -88.78%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $199.88
Upside: -19.95%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $4.69
Upside: +411.73%
Jan 9, 2023
Maintains: Sell
Price Target: $10 → $4
Current: $1.09
Upside: +266.97%
Dec 20, 2022
Maintains: Buy
Price Target: $178 → $375
Current: $475.87
Upside: -21.20%
May 24, 2022
Maintains: Neutral
Price Target: $120 → $80
Current: $20.91
Upside: +282.59%